Sonya L Heltshe

Years Active: 2015-2021
Publications (10 Years): 5

Seattle Children's Research Institute

Colorado School of Public Health (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Seattle Children's Research Institute

United States

Director of Biostatistics :: CFF Therapeutics Development Network

University of Washington School of Medicine

United States

Assistant Professor :: Pediatrics

Education History

Colorado School of Public Health

United States

PHD :: Biostatistics

Publications

David P Nichols, Pradeep K Singh, Arthur Baines, Lindsay J Caverly, James F Chmiel, Ronald L GIbson, Jorge Lascano, Sarah J Morgan, George Retsch-Bogart, Lisa Saiman, Hossein Sadeghi, Joanne L Billings, Sonya L Heltshe, Shannon Kirby, Ada Kong, Jerry A Nick, Nicole Mayer-Hamblett, null null
Testing the effects of combining azithromycin with inhaled tobramycin for P. aeruginosa in cystic fibrosis: a randomised, controlled clinical trial. Thorax (2021)
J Kirk Harris, Brandie D Wagner, Edith T Zemanick, Charles E Robertson, Mark J Stevens, Sonya L Heltshe, Steven M Rowe, Scott D Sagel
Changes in Airway Microbiome and Inflammation with Ivacaftor Treatment in Patients with Cystic Fibrosis and the G551D Mutation. Annals of the American Thoracic Society 17 (2) (2021)
Alex H Gifford, Sonya L Heltshe, Christopher H Goss
CFTR Modulator Use Is Associated with Higher Hemoglobin Levels in Individuals with Cystic Fibrosis. Annals of the American Thoracic Society 16 (3) (2020)
Sonya L Heltshe, Christopher H Goss
Optimising treatment of CF pulmonary exacerbation: a tough nut to crack. Thorax 71 (2) (2016)
Sonya L Heltshe, Christopher H Goss, Valeria Thompson, Scott D Sagel, Don B Sanders, Bruce C Marshall, Patrick A Flume
Short-term and long-term response to pulmonary exacerbation treatment in cystic fibrosis. Thorax 71 (3) (2015)

Sonya L Heltshe.css-eqlu8i{font-size:small;padding-left:4px;}